Antidepressants are one of the main classes of drugsprescribed in Western countries.
Escitalopram is the active Senantiomer of the antidepressant citalopram, and is in the class of selective serotonin reception inhibitors. It is believed that the greater availability of this neurotransmitter in the synaptic cleft may lead to indirect inhibition of the release of dopamine in the striatum, affecting the control of motor skills, generating side effects such as movement disorders.
We report a case of a 82-year-old woman, that presented generalized involuntary movements, after escitalopram treatment. The current literature is deficient in terms of evidence related to movement disorders induced by antidepressants, it is necessary that prospective studies properly designed to detect movement disorders in patients using these medications to be carried out to estimate the real incidence of these disorders.
Impact Factor
2022: 6.012
This work is licensed under a